South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugs
The shortage highlights a widening gulf in the standard of care for people with diabetes, most of whom live in low-income countries.
Doctors Test the Limits of What Obesity Drugs Can Fix
‘Obesity first’ doctors say they start with one pill, to treat obesity, and often find other chronic diseases, like rheumatoid arthritis, simply vanish
¿El estrés provoca úlceras?
Esto es lo que dicen los expertos sobre el estrés y otros factores de riesgo para las úlceras.
Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?
Mientras la FDA estudia otro nuevo medicamento contra el alzhéimer, preguntamos a los expertos qué impacto ha tenido el uso del lecanemab en sus pacientes.
Does Stress Cause Ulcers?
Here’s what the evidence suggests about this long-running claim.
How A.I. Is Revolutionizing Drug Development
In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting underway.
Akira Endo, Scholar of Statins That Reduce Heart Disease, Dies at 90
The Japanese biochemist found in the 1970s that cholesterol-lowering drugs lowered the LDL, or “bad” cholesterol, level in the blood.
Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug
The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefits
As the F.D.A. considers a new Alzheimer’s medication, we asked experts how the rollout of a similar drug has gone.
New Covid Vaccine Endorsed for Fall
The panel endorsed targeting a variant of the coronavirus that is now receding, though some officials suggested aiming at newer versions of the virus that have emerged in recent weeks.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.